- Supported exchanges /
- SHG /
- 605116.SHG
Aurisco Pharmaceutical Co Ltd (605116 SHG) stock market data APIs
Aurisco Pharmaceutical Co.,Ltd. engages in research, manufacturing, and marketing of pharmaceutical intermediates, specialty active pharmaceutical ingredients (API's), and formulations catering to the pharmaceutical market worldwide. The company offers APIs and intermediates of respiratory system, cardiovascular, anti-infection, nervous system, anti-tumor, and women's health drugs. It also provides dexamethasone is used to treat skin diseases; fluticasone propionate preparations are used to treat asthma and allergic rhinitis; fluticasone furoate preparations are used to treat asthma, allergic rhinitis, and chronic obstructive pulmonary disease; eplerenone preparations are used for the treatment of hypertension and heart failure; bepedalic acid preparations are used for the treatment of hypercholesterolemia or atherosclerotic cardiovascular diseases; tenofovir used for the treatment of HIV-1 infection and chronic hepatitis B; pregabalin preparations are used to treat neuropathic pain, fibromyalgia, epilepsy, etc.; brivaracetam preparations are used to treat epilepsy; abiraterone acetate preparation for the treatment of prostate cancer; enzalutamide preparation for the treatment of prostate cancer; and dydrogesterone preparations are used to treat dysmenorrhea, endometriosis, irregular menstrual cycle, etc. In addition, the company provides contract manufacturing services and related development works for chemicals, intermediates, and API's. Aurisco Pharmaceutical Co.,Ltd. was founded in 1998 and is headquartered in Tiantai, China.
Aurisco Pharmaceutical Co Ltd Financial Data Overview
22.17 | |
22.39 | |
- | |
22.64 | |
22.06 | |
17.1618-26.8 | |
9 091 M | |
27.2927 | |
406 M | |
1 428 M | |
0.0099 | |
-0.215 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Aurisco Pharmaceutical Co Ltd Fundamental Data is available in our Financial Data APIs
- Net Revenue 1 428 M
- EBITDA 445 M
- Earnings Per Share 0.82
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Aurisco Pharmaceutical Co Ltd Earnings via APIs
- Latest Release 2024-10-24
- EPS/Forecast NaN
Get Aurisco Pharmaceutical Co Ltd End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: